Shorter radiation beats standard in prostate cancer trial?
NCT ID NCT07489729
First seen Apr 05, 2026 · Last updated May 20, 2026 · Updated 12 times
Summary
This study compared two ways of giving radiation therapy to men with intermediate- or high-risk prostate cancer. One group received fewer, larger doses (hypofractionated), while the other got standard daily doses. Both groups also received hormone therapy. The goal was to see which approach better controls the cancer and causes fewer side effects. 60 men took part in this completed study.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER PATIENTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Tanta University
Tanta, Egypt
Conditions
Explore the condition pages connected to this study.